COPD

News

Novartis’ COPD combo show benefits in switching from establi...

A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to N

News

Early filing gives GSK a boost in COPD

Compelling data from FULFIL study puts GSK in pole position

Views & Analysis

Digital Health Round-up – new President, new ideals?

A round-up of this week’s top digital healthcare news. Marco Ricci reports.

News

Propeller Health set for expansion with latest funding round

$21.5 million in funding will be used to expand its existing roster of digitally-guided therapy solutions.

Views & Analysis

‘Real world’ COPD trial gives GSK a dose of reality

Salford Lung Study is a bold experiment, but hasn't fully paid off for GSK.

News

Novartis Breezhaler bests GSK's Seretide in COPD

Ultibro showed consistent reductions in rate of all exacerbations, whether mild, moderate, or severe.

Novartis’ COPD combo show benefits in switching from establi...

Early filing gives GSK a boost in COPD

Digital Health Round-up – new President, new ideals?

Propeller Health set for expansion with latest funding round

‘Real world’ COPD trial gives GSK a dose of reality

Novartis Breezhaler bests GSK's Seretide in COPD

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COPD

Editor's Picks